Back
Verona Pharma PLC Vs. Biodexa Pharmaceuticals Plc Industry Stock Comparison
Sell
48
VRNA
Verona Pharma PLC
Last Price:
13.03
Seasonality Move:
51.74%
Sell
50
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
1.18
Seasonality Move:
-23.05%
Sell
48
Verona Pharma PLC (VRNA)
is a Sell
Is Verona Pharma PLC a Buy, Sell or Hold?
- The current Verona Pharma PLC [VRNA] share price is $13.36. The Score for VRNA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- VRNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Is Biodexa Pharmaceuticals Plc a Buy, Sell or Hold?
- The current Biodexa Pharmaceuticals Plc [BDRX] share price is $1.24. The Score for BDRX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BDRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRNA Stock Price Chart
What is Verona Pharma PLC's stock price today?
-
The Verona Pharma PLC share price today is $13.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRNA is experiencing selling pressure, which indicates risk of future bearish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals Plc's stock price today?
-
The Biodexa Pharmaceuticals Plc share price today is $1.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.58 | Sell |
| Relative Strength Index (14 RSI): | 25.98 | Sell |
| Chaikin Money Flow: | -666731 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.45 - 15.99) | Sell |
| Bollinger Bands (100): | (15.31 - 18.31) | Sell |
BDRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 57.26 | Buy |
| Chaikin Money Flow: | 283602 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.81 - 1.23) | Buy |
| Bollinger Bands (100): | (0.93 - 1.97) | Sell |
VRNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.29 | Sell |
| 20-day SMA: | 15 | Sell |
| 50-day SMA: | 15.69 | Sell |
| 200-day SMA: | 16.44 | Sell |
| 8-day EMA: | 14.2 | Sell |
| 20-day EMA: | 14.85 | Sell |
| 50-day EMA: | 15.59 | Sell |
| 200-day EMA: | 16.54 | Sell |
BDRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.05 | Buy |
| 20-day SMA: | 1.06 | Buy |
| 50-day SMA: | 1.08 | Buy |
| 200-day SMA: | 2.91 | Sell |
| 8-day EMA: | 1.1 | Buy |
| 20-day EMA: | 1.08 | Buy |
| 50-day EMA: | 1.17 | Buy |
| 200-day EMA: | 37.84 | Sell |
Verona Pharma PLC Earnings Growth & VRNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.51 per share, and an increase next year of $0.55 per share.
Biodexa Pharmaceuticals Plc Earnings Growth & BDRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.03 per share.
Verona Pharma PLC Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biodexa Pharmaceuticals Plc Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||